Fibroblast Growth Factor Receptor (FGFR) Alterations in HPV Oropharyngeal Cancers

被引:0
|
作者
Bhateja, Priyanka [1 ]
Liu, Xuefeng [2 ]
Baliga, Sujith [3 ]
Gogineni, Emile [3 ]
Jhawar, Sachin [3 ]
Mitchell, Darrion [3 ]
Ma, Sungjun [3 ]
Zhu, Simeng [3 ]
Konieczkowski, David [3 ]
Blakaj, Dukagjin [3 ]
Old, Matthew [4 ]
Rocco, James [4 ]
Bonomi, Marcelo [1 ]
机构
[1] Ohio State Univ, James Canc Ctr, Dept Med Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, James Canc Ctr, Dept Pathol, Columbus, OH USA
[3] Ohio State Univ, James Canc Ctr, Dept Radiat Oncol, Columbus, OH USA
[4] Ohio State Univ, James Canc Ctr, Dept Otolaryngol, Columbus, OH USA
关键词
cellular effect; genomic instability; human papillomavirus; oncogenesis; proto-oncogenes; virus classification; HEAD;
D O I
10.1002/jmv.70086
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
HPV viral E6 and E7 onco-proteins play a well-known role in carcinogenesis. Host genomic alterations also play a key role in the development of HPV-related oropharyngeal cancer and have been under-recognized. We describe a case series of 6 metastatic/locoregionally recurrent HPVOPSCC patients with FGFR alterations. HPVOPSCC presents with distinct pattern of spread both temporally and sites of recurrence compared to non-HPV-related oropharyngeal cancer. Identification and reporting of genomic alterations in HPV are crucial to the understanding of disease biology and could aid in development of novel therapeutics for these patients. In addition, use of circulating tumor DNA may lead to early detection and supplement imaging in the follow up of these patients. Loco-regional treatments may also play a key role in the management of metastatic HPV OPSCC depending on the pattern of presentation. Our case series highlights all these novelties that could lead to better treatment outcomes.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Efficacy of futibatinib, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in breast cancer models with FGFR alterations
    Saridogan, Turcin
    Akcakanat, Argun
    Zhao, Ming
    Evans, Kurt W.
    Yuca, Erkan
    Scott, Stephen
    Kirby, Bryce P.
    Zheng, Xiaofeng
    Damodaran, Senthil
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2022, 82 (04)
  • [2] The frequency and somatic mutation landscape of Fibroblast growth factor receptor (FGFR) alterations in breast cancer
    Giridhar, Karthik V.
    Sokol, Ethan S.
    Vedell, Peter T.
    Sinnwell, Jason P.
    Desai, Aakash
    Haddad, Tufia C.
    O'Sullivan, Ciara C.
    Leon-Ferre, Roberto A.
    Yadav, Siddhartha
    Sideras, Kostandinos
    Ernst, Brenda
    Liu, Minetta C.
    Casey, Abe Eyman
    Tang, Xiaojia
    Fleischmann, Zoe
    Murugesan, Karthikeyan
    Kalari, Krishna R.
    Goetz, Matthew P.
    CANCER RESEARCH, 2022, 82 (04)
  • [3] Oropharyngeal cancers: Relationship between epidermal growth factor receptor alterations and human papillomavirus status
    Mirghani, H.
    Amen, F.
    Moreau, F.
    Guigay, J.
    Hartl, D. M.
    St Guily, J. Lacau
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (06) : 1100 - 1111
  • [4] Targeting fibroblast growth factor receptor (FGFR) with inhibitors in head and neck cancers: Their roles, mechanisms and challenges
    Luo, Daowen
    Kumfu, Sirinart
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    BIOCHEMICAL PHARMACOLOGY, 2025, 235
  • [5] Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib
    Karkera, Jayaprakash D.
    Cardona, Gabriela Martinez
    Bell, Katherine
    Gaffney, Dana
    Portale, Joseph C.
    Santiago-Walker, Ademi
    Moy, Christopher H.
    King, Peter
    Sharp, Michael
    Bahleda, Rastislav
    Luo, Feng R.
    Alvarez, John D.
    Lorenzi, Matthew V.
    Platero, Suso J.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1717 - 1726
  • [6] Landscape of fibroblast growth factor receptor (FGFR) genomic alterations (GA) in urothelial bladder cancer (UBC).
    Zerdan, Maroun Bou
    Bratslavsky, Gennady
    Jacob, Joseph M.
    Huang, Richard S. P.
    Kravtsov, Oleksandr
    Parimi, Vamsi
    Lin, Douglas I.
    Graf, Ryon
    Danziger, Natalie
    Ross, Jeffrey S.
    Goldberg, Hanan
    Basnet, Alina
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
    Garje, Rohan
    An, Josiah
    Obeidat, Mohammad
    Kumar, Kranthi
    Yasin, Hesham A.
    Zakharia, Yousef
    ONCOLOGIST, 2020, 25 (11): : E1711 - E1719
  • [8] Fibroblast Growth Factor Receptor (FGFR) Signalling in the Pathogenesis of Osteosarcoma
    Weekes, Q.
    Kashima, T.
    Grigoriadis, A. E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S65 - S65
  • [9] Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
    Szybowska, Patrycja
    Kostas, Michal
    Wesche, Jorgen
    Haugsten, Ellen Margrethe
    Wiedlocha, Antoni
    CELLS, 2021, 10 (06)
  • [10] Fibroblast Growth Factor Receptor Signaling in Skin Cancers
    Czyz, Malgorzata
    CELLS, 2019, 8 (06)